Bio-Path Holdings

$11.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.57 (5.04%) Today
-$0.05 (-0.42%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell BPTH and other stocks, options, ETFs, and crypto commission-free!

About BPTH

Bio-Path Holdings, Inc. Common Stock, also called Bio-Path Holdings, is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Read More Its product pipeline include Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.

Employees
8
Headquarters
Bellaire, Texas
Founded
2007
Market Cap
34.26M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
42.52K
High Today
$11.94
Low Today
$11.40
Open Price
$11.43
Volume
86.15K
52 Week High
$73.52
52 Week Low
$1.61

Collections

BPTH Earnings

-$0.89
-$0.64
-$0.40
-$0.15
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 14, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.